Search - tctmd.com

Displaying 21 - 40 of 786

Sort: Relevancy | Date

Presentation TCT 2016

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

Presenter: Chaim S. Lotan, Giora Weisz

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

Small Vessels: Svelte Stent On A Wire

Presenter: Chaim S. Lotan, Giora Weisz, Jordan Safirstein

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents IV: Nile

Presenter: Chaim S. Lotan, Giora Weisz, Ivo Petrov

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents III: Bioss

Presenter: Chaim S. Lotan, Giora Weisz, Robert J. Gil

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents II: Axxess

Presenter: Chaim S. Lotan, Giora Weisz, Christophe Dubois

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents I: Tryton

Presenter: Chaim S. Lotan, Giora Weisz, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

Presenter: Chaim S. Lotan, Giora Weisz, Martin B. Leon

October 31, 2016

Presentation TCT 2016

B Braun - ISAR Coroflex

Presenter: Marie-Claude Morice, Christian Hengstenberg

October 31, 2016

Presentation TCT 2016

Alvimedica - Cre8: Design Specifications and Results

Presenter: Marie-Claude Morice, Gennaro Sardella

October 31, 2016

Presentation TCT 2016

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Presenter: Marie-Claude Morice, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

Presenter: Marie-Claude Morice, Stephen G. Worthley

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Inspiron

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Micell

Presenter: Alexandre Abizaid, Ashok Seth, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Firehawk

Presenter: Alexandre Abizaid, Ashok Seth, Runlin Gao

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Desyne BD

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From Four Centers

Presenter: Nicolas Foin, Giampaolo Niccoli

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran

October 31, 2016

Advertisement

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Small Vessels: Svelte Stent On A Wire

Bifurcation/Left Main Stents IV: Nile

Bifurcation/Left Main Stents III: Bioss

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Bifurcation/Left Main Stents II: Axxess

Bifurcation/Left Main Stents I: Tryton

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

B Braun - ISAR Coroflex

Alvimedica - Cre8: Design Specifications and Results

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

Device Specifications and Clinical Program Update: Inspiron

Device Specifications and Clinical Program Update: Micell

Device Specifications and Clinical Program Update: Firehawk

Device Specifications and Clinical Program Update: Desyne BD

TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From Four Centers

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content